TABLE 1.

Magnetic nanoparticles conjugated with different biological receptors used in magnetic hyperthermia against different cancer cell lines.

Magnetic nanoparticle conjugates	Receptor/antigen	Cancer cell lines	Reference
Mn-Zn ferrite nanoparticles	Integrin	RAW264.7 macrophage cells, Murine mammary carcinoma cells & Human umbilical vein endothelial cells	Xie et al. (2016)
Superparamagnetic iron Oxide nanoparticles	CD44	Human and neck squamous cell carcinoma	Su et al. (2019)
Heat Shock Protein Inhibitor-loaded Silica-coated Fe3O4 nanoparticles	CD20	Lung cancer stem cells	Zhao et al. (2017); Liu et al. (2020a)
Magnetite-based nanoparticles	CD133	Colorectal cancer cells	Yang et al. (2020)
(PLGA)-coated Superparamagnetic Iron Oxide Nanoparticles	Folate receptor, transferrin receptor	Breast and glial cancer cells	Balasubramanian et al. (2014)
Dextran spermine magnetic nanoparticles	Human epithelial growth factor receptor2	Breast cancer cells	Srivastava et al. (2022b)
Polyethylene glycol-coated magnetic nanoparticles	Luteinizing hormone-releasing hormone	Ovarian cancer cells	Taratula et al. (2013)
Magnetite nanoparticles	CXCR4	Human acute T-cell leukemia	Vilas-Boas et al. (2018)
Zn+2 doped Superparamagnetic Iron Oxide Nanoparticles	Vascular endothelial growth factor	Liver cancer cells	Pan et al. (2021)